Update on Alzheimer’s Disease

Update on Alzheimer’s Disease

August 6, 2015 at 9:00 AM 0 comments

*Kurt A. Jellinger Institute of Clinical Neurobiology, Vienna, Austria *Correspondence to kurt.jellinger@univie.ac.at Disclosure: The author has declared no conflicts of interest. Received: 17.12.14 Accepted: 13.02.15 Citation: EMJ Neurol. 2015;3[1]:82-90. Abstract With the disproportionate growth of the elderly population, Alzheimer’s disease (AD), as the most common cause of dementia, has becomeRead More

Treatment of Status Epilepticus – A Narrative Review of the Evidence so Far and a Proposal for the Design of Retrospective Studies

Treatment of Status Epilepticus – A Narrative Review of the Evidence so Far and a Proposal for the Design of Retrospective Studies

August 6, 2015 at 8:58 AM 0 comments

*Johannes Rösche, Juliane Redecker Klinik für Neurologie und Poliklinik, Universitätsmedizin Rostock, Rostock, Germany *Correspondence to johannes.roesche@med.uni-rostock.de Disclosure: Dr Rösche received speaker’s honoraria from Eisai and UCB, served as medical advisor for Eisai, received travel grants from Eisai and UCB, and received financial support for an investigator-initiated trial from Pfizer. TheRead More

Status Epilepticus in Critically Ill Patients

Status Epilepticus in Critically Ill Patients

August 6, 2015 at 8:58 AM 0 comments

*Monica Rocco, Cristina Caputo, Alessandra Fegiz, Luigi Maggi, Roberto Alberto De Blasi Department of Medicine, Surgery and Translation Medicine, Sapienza University of Rome, Rome, Italy *Correspondence to monica.rocco@uniroma1.it Disclosure: The authors have declared no conflicts of interest. Received: 09.02.15 Accepted: 08.04.15 Citation: EMJ Neurol. 2015;3[1]:96-106. Abstract Status epilepticus (SE) isRead More

Sialorrhoea: How to Manage a Frequent Complication of Motor Neuron Disease

Sialorrhoea: How to Manage a Frequent Complication of Motor Neuron Disease

August 6, 2015 at 8:58 AM 0 comments

Andrea Pellegrini,1 Christian Lunetta,2 Carlo Ferrarese,1,3 *Lucio Tremolizzo,1,3 1. ALS Clinic, Neurology Unit, San Gerardo Hospital, Monza, Italy 2. NEuroMuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy 3. DCMT and Neuro-MI, University of Milano-Bicocca, Milan, Italy *Correspondence to lucio.tremolizzo@unimib.it Disclosure: The authors have declared no conflicts of interest. Received: 06.02.15Read More

Predictive Value of MRI for Clinical Outcomes

Predictive Value of MRI for Clinical Outcomes

February 10, 2015 at 10:01 AM 0 comments

Summary of presentations from the Genzyme-supported satellite symposium, held at the 22nd Annual Meeting of the European Charcot Foundation, Baveno, Italy, on 20th-22nd November 2014 Chairperson: Massimo Filippi1 Speakers: Maria Pia Sormani,2 Andrew Chan,3 Hans-Peter Hartung4 1. Vita-Salute San Raffaele University, Milan, Italy 2. University of Genoa, Genoa, Italy 3.Read More

New Approaches to Meet Patients’ Needs in Clinical Practice

New Approaches to Meet Patients’ Needs in Clinical Practice

December 9, 2014 at 9:54 AM 0 comments

Summary of Presentations from The Menarini Group-Supported Satellite Symposium, held at the 4th EHMTIC, Copenhagen, Denmark, on 19th September 2014 Chairpersons: E. Anne MacGregor,1 Stefan Evers2 Speakers: Carlo Lisotto,3 E. Anne MacGregor, Stefan Evers 1. Barts Sexual Health Centre, St Bartholomew’s Hospital and Centre for Neuroscience and Trauma, Blizard InstituteRead More

Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease

Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease

July 14, 2014 at 10:34 AM 0 comments

Summary of Presentations from the Britannia-sponsored Symposium, held at the Joint Congress of European Neurology (EFNS–ENS), Istanbul, Turkey, on 1st June 2014 Chairperson: Olivier Rascol1 Speakers:  Fabrizio Stocchi,2 Stuart Isaacson,3 William Ondo4 1. Professor, Toulouse University Hospital Clinical Investigation Centre, Toulouse, France 2. Professor, Institute of Research and Medical Care,Read More

The Evolving Ms Landscape: Challenges and Opportunities

The Evolving Ms Landscape: Challenges and Opportunities

July 14, 2014 at 10:30 AM 0 comments

Summary of Presentations from the Genzyme-Sponsored Symposium, held at the Joint Congress of European Neurology (EFNS-ENS), Istanbul, Turkey, on 2nd June 2014 Chairperson: Mefkûre Eraksoy1 Speakers: Mefkûre Eraksoy,1 Matthias Mäurer,2 Alastair Compston3 1. Department of Neurology, Istanbul Faculty of Medicine and University of Istanbul, Istanbul, Turkey 2. Department of Neurology,Read More

Paradigms: A New Initiative to Cut Through the Noise on Multiple Sclerosis a Conversation with Dr Andreas Lysandropoulos

Paradigms: A New Initiative to Cut Through the Noise on Multiple Sclerosis a Conversation with Dr Andreas Lysandropoulos

July 14, 2014 at 10:25 AM 0 comments

Interview of Andreas Lysandropoulos1 by Caroline Charles2 1. University Hospital Erasme, Brussels, Belgium 2. Scilink Medical Writing Disclosure: The project is sponsored by Genzyme EMEA for logistic and organisational purposes. Received: 23.04.14 Accepted: 22.05.14 Citation: EMJ Neurol. 2014;1:44-48.

Neuroimaging of Acute Ischaemic Stroke: Current Challenges

Neuroimaging of Acute Ischaemic Stroke: Current Challenges

July 14, 2014 at 10:22 AM 0 comments

*Susanne Wegener Department of Neurology, University Hospital Zurich, Zurich, Switzerland *Correspondence to Susanne.Wegener@usz.ch Disclosure: No potential conflict of interest. Received: 31.03.14 Accepted: 02.05.14 Citation: EMJ Neurol. 2014;1:49-52. Abstract Over the last decade, neuroimaging methods have been refined to improve clinical decisions regarding acute stroke treatment. Computed tomography and magnetic resonanceRead More